UK Government to invest $764m into new health data service
The UK Government has announced a £600m ($764m) funding pot to create a new Health Data Research Service, reducing red…
The UK Government has announced a £600m ($764m) funding pot to create a new Health Data Research Service, reducing red…
Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at…
Small and medium-sized enterprises are always looking for ways to run effective trials at a reasonable cost. It has become…
President Donald Trump has signed an executive order for the US to leave the World Health Organization (WHO). As one…
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic…
Alcon decided to take a platform-based approach to support its clinical transformation efforts when parent company Novartis decided to spin…
Ondine Biomedical will initiate a Phase III trial of its light-activated antimicrobial technology to reduce healthcare-associated infections (HAIs) early after…
CSA Medical has completed enrolment in its SPRAY-CB trial (NCT03893370) for patients with chronic obstructive pulmonary disease (COPD) with chronic…
On 4 July 2024, the people of the UK took to the polls and made their voice heard, voting for…
An AI database that utilises real-world data (RWD) could help sponsors decide where to next investigate glucagon-like peptide-1 receptor agonists…